News Sanofi showcases eczema data ahead of EU decision Dupixent predicted to be blockbuster for Sanofi
News Roche sells rights to troubled asthma and eczema drug Dermira will focus on development in eczema.
News J&J's psoriasis drug faces crowded market after US approval J&J taking on next gen drugs from Novartis, Eli Lilly, and Valeant.
News Novartis' psoriasis drug gets label boost New label shows Cosentyx is superior to J&J's rival in long-term.
News Cardiome antibiotic could reduce pressure on NHS Xydalba allows patients to be treated and quickly discharged.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
